Skip to content

Clinical Efficacy and Mechanism of Hyperbaric Oxygen in the Treatment of Acute Cerebral Infarction

Clinical Efficacy and Mechanism of Hyperbaric Oxygen in the Treatment of Acute Cerebral Infarction

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049959
Enrollment
Unknown
Registered
2021-08-15
Start date
2021-08-14
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the acute cerebral infarction

Interventions

Observation group:Hyperbaric oxygen + basic therapy

Sponsors

Yellow River Central Hospital of Yellow River Water Conservancy Commission
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 20-80 years old, NIHSS score between 1-21; 2. There are definite symptoms of neurological deficit, at least one limb hemiplegia, hemiblindness and / or aphasia. 3. Able to carry out daily life independently before onset, mRs score<= 1; 4. Cranial MRI confirms acute cerebral infarction; 5. The onset is within 72 hours; 6. Patients and their families sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Past history of internal carotid aneurysm or arteriovenous malformation; history of brain surgery or cerebral hemorrhage within the past 3 months; acute cerebral infarction within the past 3 months; 2. Severe heart disease: such as infective endocarditis, pericarditis, acute myocardial infarction, ventricular aneurysm, ventricular thrombosis, severe heart failure, etc.; 3. Serious systemic diseases: such as cancer, AIDS, advanced dementia, renal failure, active hepatitis, liver cirrhosis, portal hypertension, etc.; 4. Pregnant women; 5. Contraindications of MRI; absolute contraindications of hyperbaric oxygen (unstable vital signs, acute cerebral hemorrhage, skull fracture, bullae, emphysema, acute otitis media, etc.); 6. Body temperature >=38.5?, systolic blood pressure >=160mmHg, blood sugar =22mmol/L.

Design outcomes

Primary

MeasureTime frame
infarct volume;National Institute of Health stroke scale;Modified Rankin Scale;cerebral blood flow;adverse event;

Countries

China

Contacts

Public ContactHuang Wei

Yellow River Central Hospital of Yellow River Water Conservancy Commission

6056hw@sohu.com+86 13607695015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026